These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12948367)

  • 1. Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia.
    MacIntyre CR; Chu CP; Burgess MA
    Epidemiol Infect; 2003 Aug; 131(1):675-82. PubMed ID: 12948367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
    Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
    J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States.
    Patel MS; Gebremariam A; Davis MM
    Infect Control Hosp Epidemiol; 2008 Dec; 29(12):1157-63. PubMed ID: 18999945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different vaccination strategies in Spain and its impact on severe varicella and zoster.
    Gil-Prieto R; Walter S; Gonzalez-Escalada A; Garcia-Garcia L; Marín-García P; Gil-de-Miguel A
    Vaccine; 2014 Jan; 32(2):277-83. PubMed ID: 24275483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Varicella-Zoster Virus in England and Wales.
    Brisson M; Edmunds WJ
    J Med Virol; 2003; 70 Suppl 1():S9-14. PubMed ID: 12627480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
    Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA
    Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in U.S. Community hospitalizations due to herpes zoster: 2001-2015.
    Pham MA; Bednarczyk RA; Becker ER; Orenstein WA; Omer SB
    Vaccine; 2019 Feb; 37(6):882-888. PubMed ID: 30616954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era.
    Lin F; Hadler JL
    J Infect Dis; 2000 Jun; 181(6):1897-905. PubMed ID: 10837168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012.
    Kelly HA; Grant KA; Gidding H; Carville KS
    Euro Surveill; 2014 Oct; 19(41):. PubMed ID: 25345520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.
    Heywood AE; Wang H; Macartney KK; McIntyre P
    Bull World Health Organ; 2014 Aug; 92(8):593-604. PubMed ID: 25177074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia.
    Carville KS; Riddell MA; Kelly HA
    Vaccine; 2010 Mar; 28(13):2532-8. PubMed ID: 20117265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
    Gao Z; Gidding HF; Wood JG; MacIntyre CR
    Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom.
    Brisson M; Edmunds WJ; Law B; Gay NJ; Walld R; Brownell M; Roos LL; De Serres G
    Epidemiol Infect; 2001 Oct; 127(2):305-14. PubMed ID: 11693508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of severe varicella-zoster virus infection in Spain.
    Gil A; San-Martín M; Carrasco P; González A
    Vaccine; 2004 Sep; 22(29-30):3947-51. PubMed ID: 15364443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of viral pathogens in Australia--varicella-zoster virus.
    Roche P; Blumer C; Spencer J
    Commun Dis Intell Q Rep; 2002; 26(4):576-80. PubMed ID: 12549527
    [No Abstract]   [Full Text] [Related]  

  • 19. The epidemiology of varicella-zoster virus infections.
    Wharton M
    Infect Dis Clin North Am; 1996 Sep; 10(3):571-81. PubMed ID: 8856352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descriptive epidemiology of varicella based on national surveillance data before and after the introduction of routine varicella vaccination with two doses in Japan, 2000-2017.
    Morino S; Tanaka-Taya K; Satoh H; Arai S; Takahashi T; Sunagawa T; Oishi K
    Vaccine; 2018 Sep; 36(40):5977-5982. PubMed ID: 30166199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.